Skip to main content
Equibles

Schonfeld Strategic Advisors LLC

Position in RNA — Atrium Therapeutics, Inc.

CIK 1665241 NEW YORK, NY
Back to RNA Full portfolio

Position in RNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,678,675
+$502,588 QoQ
Shares Held
199,158
+22.4% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#17
of 154 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. RNA ranks #47 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INBX
Inhibrx Biosciences, Inc.
 697,586 $66,096,273
2 AGIO
Agios Pharmaceuticals, Inc.
 520,083 $19,300,280
3 JAZZ
Jazz Pharmaceuticals plc
 77,272 $18,620,233
4 VRDN
Viridian Therapeutics, Inc.\DE
 793,508 $14,576,741
5 MBX
MBX Biosciences, Inc.
 248,670 $13,726,584
6 XENE
Xenon Pharmaceuticals Inc.
 227,330 $13,721,638
7 PTCT
Ptc Therapeutics, Inc.
 147,425 $12,025,457
8 INSM
INSMED Inc
 104,378 $11,128,782

All Filings in RNA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,678,675 199,158
2026-03-31 $2,176,087 162,759